Berberine protects against metformin-associated lactic acidosis in induced diabetes mellitus
- سال انتشار: 1396
- محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 20، شماره: 5
- کد COI اختصاصی: JR_IJBMS-20-5_009
- زبان مقاله: انگلیسی
- تعداد مشاهده: 147
نویسندگان
Department of Medicine Liaquat University of Medical and Health Sciences Jamshoro, Sindh, Pakistan
Department of Medicine Liaquat University of Medical and Health Sciences Jamshoro, Sindh, Pakistan
Department of Medicine Liaquat University of Medical and Health Sciences Jamshoro, Sindh, Pakistan
Faculty of Medicine and Allied Medical Sciences Isra University, Hyderabad, Sindh, Pakistan
Department of Pathology Liaquat University of Medical and Health Sciences Jamshoro, Sindh, Pakistan
چکیده
Objective(s): Causality of occurrence of metformin-associated lactic acidosis (MALA) is a clinical problem. Currently, there is no drug available to prevent MALA. The present study was conducted to evaluate the protective effect of Berberine (BBR) against MALA in induced diabetic rat model. Materials and Methods: A sample of ۷۵ healthy male Wistar rats was randomly selected according to inclusion and exclusion criteria. ۷۵ male Wistar rats were randomly divided into a control and ۴ experimental groups. Streptozotocin (STZ) in citrate buffer (pH ۴.۵) at a dose of ۴۵ mg/kg was injected for induction of diabetes mellitus and rats achieving fasting blood glucose > ۲۵۰ mg/dl were included. Blood samples were collected ۱۸ hr after the last dose of metformin and berberine. Ethical approval was taken before the study was conducted. Staistix ۱۰.۰ (USA) software was used for data analysis. Results: Berberine decreased MALA. Metformin, metformin + BBR ۵۰ mg/kg bwt, and metformin + BBR ۱۰۰ mg/kg bwt showed serum lactate as ۱.۸۷±۰.۴ mmol/lL, ۱.۶۲ ± ۰.۴۴ mmol/l and ۱.۴۷± ۰.۴۵ mmol/l, respectively (P=۰.۰۰۰۱). Insulin resistance and liver enzymes were improved in BBR treated rats. Conclusion: The present study reports berberine protects against MALA in streptozocin-induced diabetes mellitus.کلیدواژه ها
Berberine, insulin resistance, Lactic acidosis, Metforminاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.